FTC sues big pharmacy benefit professionals above insulin costs The agency brought motion from Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record price of lifetime-conserving insulin medicines. This system aligns with those endeavours, the ONC explained. The industry is tackling issues https://landenspfbr.rimmablog.com/30119435/5-easy-facts-about-healthcare-news-described